Systematic review of rituximab for autoimmune diseases: a potential alternative to intravenous immune globulin
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Systematic review of rituximab for autoimmune diseases: a potential alternative to intravenous immune globulin
Authors
Keywords
-
Journal
TRANSFUSION
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2018-09-23
DOI
10.1111/trf.14841
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Rituximab in refractory myasthenia gravis: a prospective, open-label study with long-term follow-up
- (2016) Dustin Anderson et al. Annals of Clinical and Translational Neurology
- Cost-effectiveness of adding rituximab to splenectomy and romiplostim for treating steroid-resistant idiopathic thrombocytopenic purpura in adults
- (2015) Kayoko Kikuchi et al. BMC HEALTH SERVICES RESEARCH
- Cost and Resource Use of Pemphigus and Pemphigoid Disorders Pre- and Post-Rituximab
- (2015) Kara Heelan et al. JOURNAL OF CUTANEOUS MEDICINE AND SURGERY
- Rituximab as second-line treatment for adult immune thrombocytopenia (the RITP trial): a multicentre, randomised, double-blind, placebo-controlled trial
- (2015) Waleed Ghanima et al. LANCET
- Treatment of Primary Sjögren Syndrome With Rituximab
- (2014) Valérie Devauchelle-Pensec et al. ANNALS OF INTERNAL MEDICINE
- Efficacy and safety of rituximab in the treatment of non-renal systemic lupus erythematosus: A systematic review
- (2014) Tatiana Cobo-Ibáñez et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- Rituximab and dexamethasone vs dexamethasone monotherapy in newly diagnosed patients with primary immune thrombocytopenia
- (2013) S. Gudbrandsdottir et al. BLOOD
- High response rate to low-dose rituximab plus high-dose dexamethasone as frontline therapy in adult patients with primary immune thrombocytopenia
- (2013) David Gómez-Almaguer et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Changes in regulatory T cells after rituximab in two patients with refractory myasthenia gravis
- (2013) Valentina Catzola et al. JOURNAL OF NEUROLOGY
- Adverse Effects of Human Immunoglobulin Therapy
- (2013) E. Richard Stiehm TRANSFUSION MEDICINE REVIEWS
- Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: The lupus nephritis assessment with rituximab study
- (2012) Brad H. Rovin et al. ARTHRITIS AND RHEUMATISM
- A pilot randomized trial of adjuvant rituximab or placebo for nonsplenectomized patients with immune thrombocytopenia
- (2012) D. M. Arnold et al. BLOOD
- Outcomes 5 years after response to rituximab therapy in children and adults with immune thrombocytopenia
- (2012) V. L. Patel et al. BLOOD
- Trimming the fat with an IVIG approval process
- (2012) Signy Chow et al. TRANSFUSION AND APHERESIS SCIENCE
- B-cell therapies in established rheumatoid arthritis
- (2011) Maria J. Leandro et al. BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY
- Response of patients with refractory myasthenia gravis to rituximab: a retrospective study
- (2011) Richard J. Nowak et al. Therapeutic Advances in Neurological Disorders
- Predictive factors of response to rituximab therapy in rheumatoid arthritis: What do we know today?
- (2010) Maurizio Benucci et al. AUTOIMMUNITY REVIEWS
- Dexamethasone plus rituximab yields higher sustained response rates than dexamethasone monotherapy in adults with primary immune thrombocytopenia
- (2010) F. Zaja et al. BLOOD
- Low-dose rituximab in adult patients with primary immune thrombocytopenia
- (2010) Francesco Zaja et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Rituximab in patients with chronic inflammatory demyelinating polyradiculoneuropathy: a report of 13 cases and review of the literature
- (2010) L. Benedetti et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Efficacy and safety of rituximab in moderately-to-severely active systemic lupus erythematosus: The randomized, double-blind, phase ii/iii systemic lupus erythematosus evaluation of rituximab trial
- (2009) Joan T. Merrill et al. ARTHRITIS AND RHEUMATISM
- Reduction of fatigue in Sjogren syndrome with rituximab: results of a randomised, double-blind, placebo-controlled pilot study
- (2008) S Dass et al. ANNALS OF THE RHEUMATIC DISEASES
- Analysis of regulatory T-cell changes in patients with idiopathic thrombocytopenic purpura receiving B cell-depleting therapy with rituximab
- (2008) R. Stasi et al. BLOOD
- Lower dose rituximab is active in adults patients with idiopathic thrombocytopenic purpura
- (2008) F. Zaja et al. HAEMATOLOGICA
- Research electronic data capture (REDCap)—A metadata-driven methodology and workflow process for providing translational research informatics support
- (2008) Paul A. Harris et al. JOURNAL OF BIOMEDICAL INFORMATICS
- The role of IVIg in autoimmune neuropathies: the latest evidence
- (2008) Richard Hughes JOURNAL OF NEUROLOGY
- Invited Article: Inhibition of B cell functions: Implications for neurology
- (2008) M. C. Dalakas NEUROLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation